Transitional Care Program for HIV, Hepatitis C, and Substance Use Disorders

(CJC-TraC Trial)

Recruiting at 2 trial locations

Overseen By Sarah A Dietz

Age: 18+

Sex: Any

Trial Phase: Academic

Sponsor: University of Wisconsin, Madison

Disqualifiers: Impaired decision-making, Others

No Placebo Group All trial participants will receive the active study treatment (no placebo)

Compensation: Varies

Number of Visits: 5

219 Participants Needed

Trial Summary

What is the purpose of this trial?

This trial tests a program called CJC-TraC that helps people leaving prison get the medical care they need. It focuses on those with HIV, Hepatitis C, or substance misuse history. The program coordinates their medical care to ensure they continue treatment after release. New treatments have made it easier and faster to cure Hepatitis C.

Research Team

Ryan Westergaard, MD, PhD, MPH

Principal Investigator

UW School of Medicine and Public Health

Eligibility Criteria

This trial is for incarcerated individuals in Wisconsin who are eligible for Medicaid and will be released within 6 months. They must understand English, plan to stay in Wisconsin post-release, and have HIV, Hepatitis C or a history of substance misuse.

Inclusion Criteria

Plans to reside in Wisconsin after release

Able to understand and speak in English

Eligible for Wisconsin Medicaid and willing to enroll prior to release

Exclusion Criteria

Planned discharge to another correctional facility or other carceral setting (e.g. release to jail or immigration detention center)

I am able to understand and make decisions about my health care.

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Pre-release Intervention

Participants engage in CJC-TraC intervention sessions with a nurse case manager before release

up to 3 months

3 sessions (in-person)

Post-release Intervention

Participants have post-release telephone contacts with the CJC-TraC nurse case manager

up to 6 months

2 sessions (telephone)

Follow-up

Participants are monitored for safety and effectiveness after intervention

3 months

Treatment Details

Interventions

• CJC-TraC

Trial Overview The study tests the Coordinated Transitional Care intervention (CJC-TraC) adapted for those transitioning from incarceration back into society. It focuses on people with HIV, Hepatitis C or substance use disorders over a period of up to 6 months.

Participant Groups

Group I: CJC-TraC Intervention Experimental Treatment 1 Intervention

Incarcerated individuals with HIV, hepatitis C, or substance use disorder readying for release will enroll in the CJC-TraC intervention intended to assist in transitioning their health care.

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials

1,249

Recruited

3,255,000+

National Institute on Drug Abuse (NIDA)

Collaborator

Trials

2,658

Recruited

3,409,000+